ID: ALA4874658

Max Phase: Preclinical

Molecular Formula: C36H45N7O5

Molecular Weight: 655.80

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O

Standard InChI:  InChI=1S/C36H45N7O5/c37-17-5-4-9-30(34(39)46)42-35(47)31(19-23-11-13-25(14-12-23)24-7-2-1-3-8-24)43-36(48)32(41-33(45)10-6-18-38)20-26-22-40-29-16-15-27(44)21-28(26)29/h1-3,7-8,11-16,21-22,30-32,40,44H,4-6,9-10,17-20,37-38H2,(H2,39,46)(H,41,45)(H,42,47)(H,43,48)/t30-,31-,32-/m0/s1

Standard InChI Key:  UAQQDAYCKBFCNC-CPCREDONSA-N

Associated Targets(Human)

Ephrin type-A receptor 4 2022 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 655.80Molecular Weight (Monoisotopic): 655.3482AlogP: 2.13#Rotatable Bonds: 18
Polar Surface Area: 218.45Molecular Species: BASEHBA: 7HBD: 8
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.47CX Basic pKa: 10.29CX LogP: 0.56CX LogD: -3.31
Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.07Np Likeness Score: 0.10

References

1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M..  (2021)  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.,  64  (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608]

Source